| Document |
Document Title |
|
JPH0115492B2 |
A compound of the general formula wherein n is an integer of 10 to 21, inclusive; R is H or lower alkyl having 1 to 4 carbon atoms has pharmaceutical activities such as hypotensive, tissue metabolism stimulating, immuno-regulatory, lysos...
|
|
JPH0115491B2 |
PCT No. PCT/JP81/00046 Sec. 371 Date Oct. 30, 1981 Sec. 102(e) Date Oct. 30, 1981 PCT Filed Mar. 6, 1981 PCT Pub. No. WO81/02574 PCT Pub. Date Sep. 17, 1981.1,4-naphthoquinone derivatives represented by the following general formula: (wh...
|
|
JPH0114215B2 |
|
|
JPS6461441A |
NEW MATERIAL: Anthraquinones shown as the formula I {R1 and R2 are each H or 1-5C alkyl; R3 is H, 1-5C alkyl, -CH2C6H4OH, -C(CH3)2C6H4OH; (n) is 1 to 3; X is H, the formula II, -CmH2mCOOH [(m) is 1 to 12] or -CmH2mCONR' NH2 (R' is H or 1...
|
|
JPS6461448A |
NEW MATERIAL: Anthraquinones of formula I [X is -CR2R3 (R2 is H, -CN or 1-5C alkyl; R3 is H or -CN); R1 is H or 1-5C alkyl; R is a direct bond or linear or branched 1-18C alkylene (which, alone or together with the -CR2R3- group, can be ...
|
|
JPS6461440A |
PURPOSE: To prepare the pest-combating agent contg. at least one king of substituted 1,4-naphthoquinones some of which are new and showing strong acaricidal, bactericidal and fungicidal effects. CONSTITUTION: This pest-combating agent co...
|
|
JPS6456767A |
NEW MATERIAL: Compounds of formula I [wherein, (n) is 1 to 17; (k) is 1 or 2; Q is COOH, CONR4 or NH2 (R4 is H or a 1-4C alkyl); e.g. (k) is 1 and Q is OH, NHR4, OCOR5 (R5 is a mono-decarboxylized group of a tricarboxylic acid, etc.), et...
|
|
JPS6456644A |
NEW MATERIAL:A compound shown by formula 1 (R1 and R2 are lower alkyl or cycloalkyl). EXAMPLE: 3,3'-Dihydroxy-2,2'-dimethyl-5,5'-diisopropyl-4,4'-diphenoqu
inone. USE: Useful as a chelating agent, dyestuff, preformed chemical mediator, l...
|
|
JPH0112727B2 |
A mammal suffering from ischemic disease such as cerebral apoplexy, cadiac insufficiency, renal insufficiency due to hypertensive vasculer lesions, etc. is remedied by administering to said mammal an effective amount of a compound of the...
|
|
JPS649305B2 |
|
|
JPS6439391A |
PURPOSE:To increase the efficiency of electrolytic operation when alkylphenolsulfonic acids represented by a specified general formula are anodically oxidized in an electrolytic cell, by subjecting anolyte to extraction at the outside of...
|
|
JPS6438302A |
PURPOSE: To alleviate labor with the titled device in a department store or the like by storing arriving commodities sorted on a temporary storage transfer cart in a temporary storage location and by performing the transfer between the t...
|
|
JPS645585B2 |
|
|
JPS645584B2 |
|
|
JPS6429338A |
NEW MATERIAL: Tetracycline derivatives represented by the formula I (wherein: R1 is H or OH; R2 is H, OH or a group represented by the formula II (wherein R4 is an aliphatic or aromatic acyl group); and R3 is OH or a group represented by...
|
|
JPS646221A |
PURPOSE: To obtain the titled compound advantageously, by subjecting an organic monohalogen compound or sulfonic acid aryl ester and a metallic acetylide to coupling reaction in the presence of an alkyl-2-imidazolidinone as a reaction pr...
|
|
JPS63313724A |
PURPOSE: To obtain a ribosome coating body significantly reduced in phagosome number and lowered in vanishing speed of the ribosome in blood, by coating ribosome membrane surface containing ubidecarenone with a specific modifying polysac...
|
|
JPS6365058B2 |
|
|
JPS6363024B2 |
PURPOSE:To improve yield of deposition of starting material for catalytically active substance to carrier, strength of deposition of the catalyst, catalytic activity and/or selectivity by using whisker for the carrier aid. CONSTITUTION:1...
|
|
JPS6358829B2 |
|
|
JPS6356821B2 |
|
|
JPS63250338A |
Psoriasis in mammals is relieved by administering naphthalenes of the formula: wherein: R<1> is lower alkoxy or optionally substituted phenoxy; R<2> is hydrogen, lower alkyl, lower alkoxy, optionally substituted phenyl, optionally substi...
|
|
JPS63250339A |
Psoriasis in mammals is relieved by topically administering naphthalenes of the formula: wherein: R<1> is lower alkoxy or optionally substituted phenoxy; R<2> is hydrogen, lower alkyl, optionally substituted phenyl or optionally substitu...
|
|
JPS6351123B2 |
A mammal suffering from allergic disease due to SRS-A, such as skin symptoms, asthma, rhinitis, etc. is treated by administering to said mammal an effective amount of a compound of the formula: wherein R is methoxy or methyl, or two R's ...
|
|
JPS6350337B2 |
|
|
JPS63239238A |
A process is described for preparing optically active alpha-halogenated carbonyl compounds.This process consists of transforming the carbonyl compound into the corresponding acetal with tartaric acid or a derivative thereof, halogenati...
|
|
JPS63235390A |
PURPOSE: To provide the title polymerization inhibitor which is excellent in the effect of inhibiting the polymerization of a vinyl compd. and the handleability and is free from the problem with respect to environmental sanitation, which...
|
|
JPS63230093A |
PURPOSE: To enable efficient production of the titled compound, by transducing part of Ri plasmid of Agrobacterium rhizogenes to a cell of plant of the family Boraginaceae, transforming the cell to give a hair root, cultivating the hair ...
|
|
JPS6346734B2 |
|
|
JPS6346733B2 |
|
|
JPS6346061B2 |
|
|
JPS6346060B2 |
|
|
JPS6342611B2 |
|
|
JPS63190849A |
PURPOSE: To collect 1,4-naphthoquinone efficiently in bringing a formed hot gas obtained by catalytic vapor phase oxidation of naphthalene with molecular oxygen-containing gas, by suppressing remarkable foaming by the use of a Venturi sc...
|
|
JPS63190848A |
PURPOSE: To obtain 1,4-naphthoquinone economically, by gradually raising a heating rate or increasing O2 content in an O2-containing gas to cautiously regenerate a catalyst having lowered activity and catalytically oxidizing naphthalene ...
|
|
JPS63190847A |
PURPOSE: To obtain 1,4-naphthoquinone in high yield even by using coal-based naphthalene, by using air having sulfur content in fixed range and pretreating a vanadium pentoxide-potassium sulfate-potassium pyrosulfate at a specific temper...
|
|
JPS63190846A |
PURPOSE: To obtain the titled compound by a simplified process in high yield, by limiting sulfur content in a raw material and a reaction temperature to specific ranges and catalytically oxidizing coal-based naphthalene in vapor phase in...
|
|
JPS63188623A |
PURPOSE: To obtain a preparation for oral administration, by adding a middle- chain fatty acid monoglycerin ester to ubidecarenone. CONSTITUTION: 1pt.wt. ubidecarenone is blended with 0.5W150pts.wt. middle-chain fatty acid monoglycerin e...
|
|
JPS63185921A |
PURPOSE: To obtain a remedy for hepatic diseases, by using a quinone derivative or its hydroquinone compound as an active component. CONSTITUTION: The objective remedy for hepatic diseases contains a compound of formula (R1 and R2 are me...
|
|
JPS6337775B2 |
|
|
JPS6335637B2 |
|
|
JPS6334141B2 |
|
|
JPS63162649A |
PURPOSE: To obtain all trans form vitamin K2 of natural type having slight side effects and high medicinal activity, irradiating a solution of cis form vitamin D2 or cis-trans form mixed vitamin K2 with laser beam optionally in the prese...
|
|
JPS6332344B2 |
|
|
JPS63156742A |
NEW MATERIAL:A 14-(ω,ω,ω-trifluoroalkyl)-4-demethoxydaunomycinone derivative expressed by formula I (R1 is H or OH; n is 1W3). EXAMPLE: (+)-14-(2,2,2-Trifluoroethyl)-4-demethoxydaunomyucinone. USE: A medicine and raw material for prod...
|
|
JPS6332057B2 |
NEW MATERIAL:A quinone compound of formula I (n is an integer of 1-10; R<1> is methyl, methoxy, or two R<1> together form -CH=CH-CH=CH-; R<2> is lower alkyl), or its hydroquinone. USE:Hypotensor, analgesic antiulcer agent, antiphlogistic...
|
|
JPS6332056B2 |
HCH:CH; Y1=H, OH, CO2H, CN, acyloxy, optionally substituded CONH2; X=CH:CH, C:C; m=0-3; n=0-10; n'1-5; k=1-3) and their pharamaceutically acceptive salts were prepd. Thus, II was treated with 2, 6-dicarboxypyridine N-oxide and ceric ammo...
|
|
JPS63139125A |
PURPOSE: To obtain an inexpensive aromatase inhibitor useful for preventing and treating estrogen-dependent diseases such as mammary cancer, etc., containing a naphthoquinone compound. CONSTITUTION: A 1,4-naphthoquinone or a 1,2-naphthoq...
|
|
JPS63501288A |
PCT No. PCT/US86/01852 Sec. 371 Date May 18, 1987 Sec. 102(e) Date May 18, 1987 PCT Filed Sep. 5, 1986.Novel 1,4-naphthalenediol and 1,4-hydroquinone derivatives of formulas I, II, III and IV and their therapeutic uses as 5-lipoxygenase ...
|
|
JPS6323179B2 |
Process for the decomposition of complexes of orthobenzoyl-benzoic acid, hydrogen fluoride, and boron trifluoride in which the complex is subjected to the action of sulfuric acid in a concentration of at least about 96% by weight or to t...
|
